Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial

Latamoxef for Neonates With Early-Onset Neonatal Sepsis: A Study Protocol for a Randomized Controlled Trial

Early-onset neonatal sepsis (EONS), a bacterial infection that occurs within 72 h after birth, is associated with high likelihood of neonatal mortality. Latamoxef, a semi-synthetic oxacephem antibiotic developed in 1980s, has been brought back into empirical EONS treatment in recent years. In the pr...

Full description

Bibliographic Details
Main Authors: Hui Qi, Yue-E Wu, Ya-Li Liu, Chen Kou, Ze-Ming Wang, Xiao-Xia Peng, Liang Chen, Hong Cui, Ya-Juan Wang, Jie-Qiong Li, Wei Zhao, A-Dong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Pharmacology
Subjects:
latamoxef
early-onset neonatal sepsis
neonate
randomized controlled trial
study protocol
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.635517/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.635517/full

Similar Items